Clinical trial
BOrrelia BUrgdorferi IN Children and Adolescents- a Seroprevalence Study
NCT05856812 is registered in ClinicalTrials.gov with University Children's Hospital Basel as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- BOrrelia BUrgdorferi IN Children and Adolescents- a Seroprevalence Study
- Lead sponsor
- University Children's Hospital Basel
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 23, 2023
- Completion date
- February 6, 2024
- Enrollment
- 962 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
b. burgdorferi infection